In the constructed pan-cancer drug–gene network, the top hub gene of the network was mTOR, which interacted with 45 drugs, followed by BCL2, STAT3, and EGFR (Fig. 3A; Supplementary Table S8). The gene discussed is BCL2; the disease is cancer.